HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.

Abstract
Betulinic acid, a naturally occurring triterpene found in the bark of the white birch tree, has been demonstrated to induce programmed cell death with melanoma and certain neuroectodermal tumor cells. We demonstrate currently that treatment of cultured UISO-Mel-1 (human melanoma cells) with betulinic acid leads to the activation of p38 and stress activated protein kinase/c-Jun NH(2)-terminal kinase [widely accepted proapoptotic mitogen-activated protein kinases (MAPKs)] with no change in the phosphorylation of extracellular signal-regulated kinases (antiapoptotic MAPK). Moreover, these results support a link between the MAPKs and reactive oxygen species (ROS). As demonstrated previously, cells treated with betulinic acid generate ROS. Preincubation of cells with antioxidants blocks the process of programmed cell death, and prevents the phosphorylation of p38 and stress activated protein kinase/c-Jun NH(2)-terminal kinase. These data suggest that ROS act upstream of the MAPKs in the signaling pathway of betulinic acid. In addition to mediating these responses, treatment of cells with betulinic acid resulted in a gradual depolarization of mitochondrial membrane potential, a phenomenon established to contribute to the induction of programmed cell death. Interestingly, p38 was capable of partially modulating this perturbation, and investigations of mitochondria-associated apoptotic events indicate no involvement of known caspases. These data provide additional insight in regard to the mechanism by which betulinic acid induces programmed cell death in cultured human melanoma cells, and it likely that similar responses contribute to the antitumor effect mediated with human melanoma carried in athymic mice.
AuthorsYingMeei Tan, Rong Yu, John M Pezzuto
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 9 Issue 7 Pg. 2866-75 (Jul 2003) ISSN: 1078-0432 [Print] United States
PMID12855667 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Antioxidants
  • Pentacyclic Triterpenes
  • Reactive Oxygen Species
  • Triterpenes
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Betulinic Acid
Topics
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Antioxidants (pharmacology)
  • Apoptosis
  • Blotting, Western
  • Caspase 3
  • Caspases (metabolism)
  • Cell Line, Tumor
  • Enzyme Activation
  • Flow Cytometry
  • Humans
  • Intracellular Membranes (metabolism)
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Signaling System
  • Melanoma (drug therapy, pathology)
  • Membrane Potentials
  • Mitogen-Activated Protein Kinases (metabolism)
  • Pentacyclic Triterpenes
  • Phosphorylation
  • Reactive Oxygen Species
  • Time Factors
  • Triterpenes (pharmacology)
  • p38 Mitogen-Activated Protein Kinases
  • Betulinic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: